1951
DOI: 10.1136/jnnp.14.3.216
|View full text |Cite
|
Sign up to set email alerts
|

Subacute Necrotizing Encephalomyelopathy in an Infant

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

11
380
0
8

Year Published

1961
1961
2017
2017

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 727 publications
(405 citation statements)
references
References 6 publications
(5 reference statements)
11
380
0
8
Order By: Relevance
“…Since its initial description (Leigh 1951), LS has evolved from a distinct neuropathological disorder defined by postmortem histopathological findings to a clinical entity characterized by progressive neurodegenerative disease with symptoms and signs of brainstem and/or basal ganglia disease, raised lactate levels in blood and/or cerebrospinal fluid (CSF), and typical neuroimaging and/or neuropathological abnormalities (Rahman et al 1996). More recently, Baertling et al (2014) refined the diagnostic criteria to include the three most commonly described features: (1) neurodegenerative disease with variable symptoms; (2) bilateral neuroimaging or CNS lesions and (3) a variety of nuclear or mitochondrially encoded genetic causes of deficient mitochondrial energy metabolism.…”
Section: Introductionmentioning
confidence: 99%
“…Since its initial description (Leigh 1951), LS has evolved from a distinct neuropathological disorder defined by postmortem histopathological findings to a clinical entity characterized by progressive neurodegenerative disease with symptoms and signs of brainstem and/or basal ganglia disease, raised lactate levels in blood and/or cerebrospinal fluid (CSF), and typical neuroimaging and/or neuropathological abnormalities (Rahman et al 1996). More recently, Baertling et al (2014) refined the diagnostic criteria to include the three most commonly described features: (1) neurodegenerative disease with variable symptoms; (2) bilateral neuroimaging or CNS lesions and (3) a variety of nuclear or mitochondrially encoded genetic causes of deficient mitochondrial energy metabolism.…”
Section: Introductionmentioning
confidence: 99%
“…cDNA and protein mutations and annotations regarding animal models are also useful potential supplements to the Leigh Map. Leigh syndrome is a defined disorder5 wherein certain phenotypes appear almost ubiquitously, including hypotonia (91% of patients), developmental delay (82%), lactic acidosis (78%), and failure to thrive (61%). The failure to deduce the correct candidate genes for a minority of our test cases was due to the predominant presence of these common Leigh syndrome phenotypes and a lack of discriminating phenotypes.…”
Section: Future Prospectsmentioning
confidence: 99%
“…Leigh syndrome is a progressive neurodegenerative disorder defined neuropathologically by spongiform basal ganglia and brainstem lesions 4, 5. Clinical manifestations include psychomotor retardation, with regression, and progressive neurological abnormalities related to basal ganglia and/or brainstem dysfunction, often resulting in death within 2 years of initial presentation 4, 6.…”
mentioning
confidence: 99%
“…Leigh Syndrome (Bilateral Symmetric Basal Ganglia Lesions) Denis Leigh, a British neuropathologist, first described this syndrome in 1951, in a 7-month-old patient with "subacute necrotizing encephalomyelopathy" [90]. Neuroimaging shows calcifications on computed tomography or MRI with bilateral and symmetric lesions of the basal ganglia, periaqueductal grey, pons, midbrain, brainstem, cerebellum, and, rarely, white matter [91,92].…”
Section: Stroke-like Lesions In Nonvascular Distributionmentioning
confidence: 99%